• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
    • Editorial Board
    • Contact
  • Issues
    • Current Issue
    • Issue Archives
  • Multimedia
  • Editor's Update
  • Advertise
  • Reprints
  • Authors & Reviewers
    • Author Instructions
    • Submission Portal
    • Reviewers

Search

Simbionix Releases Lower Limb Training Module for the ANGIO Mentor Endovascular Simulator

Simbionix USA Corporation, the world's leading provider of medical simulation, training and education products, announces increasing its library of training opportunities on the ANGIO Mentor with the new Below-The-Knee (BTK) module.

The Simbionix ANGIO Mentor products are multidisciplinary surgical simulators that provide hands-on practice of endovascular procedures in a virtual reality simulated environment.

Lower-limb ischemia, a Peripheral Arterial Disease (PAD), is a vascular disorder which occurs when oxygen supply to the leg tissues is reduced due to poor blood flow caused by atherosclerosis.

Patients with Critical Limb Ischemia present with rest pain, which may progress to ulceration and gangrene, experience high amputation rates, significant morbidity and cardiovascular events. Undergoing endovascular below-the-knee revascularization may increase the possibility of saving the limb.

Still, Critical Limb Ischemia is associated with multi-segmental complex arterial lesions, which contribute to the challenge of these procedures. Developments in medical devices and recent advancement in techniques help surgeons overcome these procedural challenges. The Simbionix BTK simulation module helps surgeons build confidence with the clinical and practical aspects of BTK Interventions using the latest techniques and therapeutic approaches available.

The module was developed in collaboration with leading worldwide physicians, including Dr. Andrej Schmidt from the Center for Vascular Medicine, Parkhospital and Heartcenter Leipzig, Germany. "The role of endovascular therapy for patients with critical limb ischemia is steadily increasing. Therefore skills to treat infrapopliteal arteries is extremely important, which are clearly completely different to treat than iliac or femoropopliteal lesions. Simbionix module for BTK interventions is, in our opinion, a very important learning-tool and perfectly brought into praxis."

"The ANGIO Mentor provides a complete training solution to learners of all levels and across multiple disciplines," said Gary Zamler, Simbionix CEO. "The new BTK module was very well received by doctors of all skills levels, who all commented on the high realism of the simulated procedure in comparison to other available products. The ANGIO Mentor's true value lies within its vast training opportunities [http://simbionix.com/simulators/angio-mentor/library-of-modules/below-the-knee ]. As we strive to offer our customers the best ROI, we continuously develop new modules for this robust simulator to answer the needs of endovascular surgeons."

To experience the ANGIO Mentor hands-on, visit Simbionix at the training sessions at SVS, June 6-8, in National Harbor, MD.

Bookmark/Search this post with
  • Digg
  • LinkedIn
  • Reddit
  • Facebook Like
  • Google Plus One
  • Linkedin Share Button
  • Tweet Widget
image description image description


				
  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Kimberly Sutkowski, Classified Sales Representative
    (800) 237-7285, ext. 205

Vascular Access: The VDM Clinician Blog

Anticoagulant Treatment of DVT and Preventing DVT-PE Made Easier

Frank J Criado MD FACS FSVM

Retrograde Crossing: When the Front Door Is Locked, Look for Another Way In!

Ajay U. Mhatre MD

Collecting More Data for Vascular Patients

Lawrence A. Garcia MD

A Road Less Traveled: Access in the Right Brachial Artery

Ajay U. Mhatre MD

Endovascular Options for Complex Abdominal Aortic Aneurysms

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT
more »

Vascular Newswire

  • Elixir Medical Receives CE Mark Approval for the Fully Bioresorbable DESolve Novolimus Eluting Coronary Scaffold System
    Wed, 05/15/13 - 10:12am
  • Reverse Medical Corporation Announces CE Mark and Initial Clinical Experience with the MVP Micro Vascular Plug for Peripheral Embolization
    Wed, 05/15/13 - 8:55am
  • St. Jude Medical Announces First Patient Enrollment in EnligHTN III Renal Denervation Study of Next-Generation EnligHTN System
    Wed, 05/15/13 - 8:52am
  • Decades of Improving Cholesterol Levels Abruptly Ended in 2008, PLOS ONE Study Finds
    Tue, 05/14/13 - 10:02am
more »

Clinical Events Calendar

  • New Frontiers in Endovascular Therapy
    Fri, 05/17/2013 - Sat, 05/18/2013
    Jacksonville, FL, United States
  • EuroPCR 2013
    Tue, 05/21/2013 - Fri, 05/24/2013
    Paris, France
  • European Society for Vascular Surgery European Vascular Trauma Workshop
    Mon, 05/27/2013 - Tue, 05/28/2013
    Sweden
more »

Poll

Drug-eluting balloons will have a major role in lower-extremity revascularization in the future.:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2013 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2013 HMP Communications